Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michał Brzdęk

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Advances in Medical Sciences|January 14, 2023
Genotype 4 hepatitis C virus-a review of a diverse genotypeMichał Brzdęk, Krystyna Dobrowolska, Robert Flisiak, et al.
Polish Archives of Internal Medicine|August 8, 2022
Clinical characteristics and antiviral therapy in patients infected with hepatitis C virus in the interferon‑free eraMichał Brzdęk, Krystyna Dobrowolska, Paweł Pabjan, et al.
Journal of Clinical Medicine|June 13, 2025
Swept-Source Optical Coherence Tomography in the Diagnosis and Monitoring of Optic Nerve Neuropathy in Patients with Wernicke's Encephalopathy Due to Hyperemesis GravidarumMagdalena Kal, Michał Brzdęk, Justyna Tracz, et al.
Clinical and Experimental Hepatology|September 4, 2025
Hepatic involvement in major respiratory viral infectionsPiotr Rzymski, Krystyna Dobrowolska, Michał Brzdęk, et al.
Vaccines|August 26, 2022
COVID-19 Vaccine Booster Strategies for Omicron SARS-CoV-2 Variant: Effectiveness and Future ProspectsDorota Zarębska-Michaluk, Chenlin Hu, Michał Brzdęk, et al.
Polish Archives of Internal Medicine|January 2, 2024
Hepatitis B virus coinfection in patients treated for chronic hepatitis C: clinical characteristics, risk of reactivation with long-term follow-up, and effectiveness of antiviral therapyDorota Zarębska-Michaluk, Michał Brzdęk, Piotr Rzymski, et al.
Expert Review of Anti-Infective Therapy|March 29, 2025
Treatment of chronic hepatitis C infection: strategies to address poor therapy adherenceRobert Flisiak, Piotr Rzymski, Marta Flisiak-Jackiewicz, et al.
Advances in Medical Sciences|July 7, 2024
Characteristics of the radial peripapillary capillary network in patients with COVID-19 based on optical coherence tomography angiography: A literature reviewMagdalena Kal, Michał Brzdęk, Izabella Karska-Basta, et al.
World Journal of Gastroenterology|February 27, 2023
Decade of optimizing therapy with direct-acting antiviral drugs and the changing profile of patients with chronic hepatitis CMichał Brzdęk, Dorota Zarębska-Michaluk, Federica Invernizzi, et al.
Cancers|July 15, 2026
Risk of Liver and Non-Liver Malignancy in HCV-Infected Patients with Cirrhosis After Direct-Acting Antiviral TreatmentDorota Zarębska-Michaluk, Krystyna Dobrowolska, Robert Flisiak, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Advances in Medical Sciences|January 14, 2023
Genotype 4 hepatitis C virus-a review of a diverse genotypeMichał Brzdęk, Krystyna Dobrowolska, Robert Flisiak, et al.
Polish Archives of Internal Medicine|August 8, 2022
Clinical characteristics and antiviral therapy in patients infected with hepatitis C virus in the interferon‑free eraMichał Brzdęk, Krystyna Dobrowolska, Paweł Pabjan, et al.
Journal of Clinical Medicine|June 13, 2025
Swept-Source Optical Coherence Tomography in the Diagnosis and Monitoring of Optic Nerve Neuropathy in Patients with Wernicke's Encephalopathy Due to Hyperemesis GravidarumMagdalena Kal, Michał Brzdęk, Justyna Tracz, et al.
Clinical and Experimental Hepatology|September 4, 2025
Hepatic involvement in major respiratory viral infectionsPiotr Rzymski, Krystyna Dobrowolska, Michał Brzdęk, et al.
Vaccines|August 26, 2022
COVID-19 Vaccine Booster Strategies for Omicron SARS-CoV-2 Variant: Effectiveness and Future ProspectsDorota Zarębska-Michaluk, Chenlin Hu, Michał Brzdęk, et al.
Polish Archives of Internal Medicine|January 2, 2024
Hepatitis B virus coinfection in patients treated for chronic hepatitis C: clinical characteristics, risk of reactivation with long-term follow-up, and effectiveness of antiviral therapyDorota Zarębska-Michaluk, Michał Brzdęk, Piotr Rzymski, et al.
Expert Review of Anti-Infective Therapy|March 29, 2025
Treatment of chronic hepatitis C infection: strategies to address poor therapy adherenceRobert Flisiak, Piotr Rzymski, Marta Flisiak-Jackiewicz, et al.
Advances in Medical Sciences|July 7, 2024
Characteristics of the radial peripapillary capillary network in patients with COVID-19 based on optical coherence tomography angiography: A literature reviewMagdalena Kal, Michał Brzdęk, Izabella Karska-Basta, et al.
World Journal of Gastroenterology|February 27, 2023
Decade of optimizing therapy with direct-acting antiviral drugs and the changing profile of patients with chronic hepatitis CMichał Brzdęk, Dorota Zarębska-Michaluk, Federica Invernizzi, et al.
Cancers|July 15, 2026
Risk of Liver and Non-Liver Malignancy in HCV-Infected Patients with Cirrhosis After Direct-Acting Antiviral TreatmentDorota Zarębska-Michaluk, Krystyna Dobrowolska, Robert Flisiak, et al.
Pageof 5